NEFL and myeloid sarcoma: The results reported a significant reduction of NfL in the exercise study group compared to the control group, suggesting that NfL may be a promising biomarker to understand the regulation of disease activity via exercise in MS patients and could be viable for future study with exercise and CIPN.